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Abstract: In this work, composite Eudragit L100 / phosphatidyl choline microparticles were fabricated14
through electrospraying. pH-responsive liposomes were found to self-assemble from these when the15
microparticles were added into aqueous media. The microparticles and the liposomes were both16
approximately spherical in shape according to electron microscopy, but the liposomes have much17
smaller diameters (200-300 nm) than the electrosprayed particles (1.6-1.7 µm). The zeta potential of18
the liposomes is approximately -30 mV, which suggests the formation of stable suspensions. Varying19
the pH conditions used for self-assembly causes the liposomes to change their shape and structure, due20
to the influence of Eudragit molecules. The model drug ketoprofen could be loaded into the liposomes,21
with an entrapment efficiency of 75%. pH-dependent release was observed from the drug-loaded22
liposomes. At pH 4.5, only 58% of the drug loaded was released after 12 hours while 80% was released23
at pH 7.4. Overall, these results demonstrate that the pH-dependent liposomes developed have great24
potential for application as stimuli-responsive drug delivery systems.25
26




2In recent years, a range of pH-sensitive liposomes, which can control the release of a loaded drug in1
response to the pH of the surrounding medium, have been reported [1-3]. These liposomes can serve as2
carriers of many different active ingredients, for instance small organics, peptides, RNA, DNA, and3
diagnostic agents [4-7]. They also generally have good biocompatibility [8]. There are two key types of4
pH-dependent liposomes, which are bounded either by natural lipid bilayers or polymer functionalized5
lipid bilayers. A pH-driven phase transition of the lipid bilayers or of the polymer attached to them6
permits their contents to be freed into solution in a responsive manner [9]. However, natural7
phospholipid-based liposomes usually have low stability at low pH values [10]. It is therefore desirable8
to prepare polymer-functionalized systems to improve stability.9
10
Many studies have reported that liposomes decorated with pH-sensitive polymers are capable of11
pH-responsive release [11-13]. Eudragit L100, which is synthesized from methacrylic acid and12
methacrylic acid methyl ester, is a pH-sensitive polymer widely used in the pharmaceutical industry,13
for instance as enteric coatings for tablets. It can also be employed for preparing microspheres and14
nanoparticles for use as targeted gastro-intestinal drug delivery systems [14, 15]. Eudragit L10015
dissolves only at pH values higher than 6.0, and is insoluble in aqueous media below this pH. Thus, it16
can be specifically applied to release an incorporated drug only in the lower parts of the17
gastro-intestinal tract [16].18
19
A number of methods can be applied to obtain pH-sensitive liposomes. For instance, Straubinger et al.20
used oleic acid and phosphatidylethanolamine to fabricate pH-sensitive liposomes via the evaporation21
method [17]. In other work, Catalan-Latorre et al. fabricated multicompartment liposomes loaded with22
curcumin through combining Eudragit S100, hyaluronic acid and a phospholipid using the23
freeze-drying method [18]. However, these methods can be complex, and often there is solvent residue24
in the multicomponent liposomes. As a result, researchers have sought alternative methods for25
producing liposomes [19-21].26
27
Liposomes form as a result of molecular self-assembly, driven by noncovalent interactions. The28
spontaneous association of amphiphilic molecules, isolating lipophilic sections from an aqueous29
medium, for instance, leads to the creation of stable and well-defined supramolecular structures [22].30
3This approach is important for the fabrication of biomaterials [23-25], but it is challenging to control1
such a bottom-up process. Therefore, methods to direct the contacts between building blocks and drive2
the assembly process towards a desired conclusion are required.[26-28].3
4
One route that may be used to obtain control over self-assembly processes is electrospraying, a5
hydrodynamic atomization approach. This is a top-down process which exploits electrical energy to6
evaporate the solvent from a polymer solution, resulting in solid dispersions in the form of7
sub-micron-sized particles. Electrospinning is a similar technique, and yields nanoscale fibers. Both8
electrosprayed particles and electrospun fibers can be exploited as templates to direct the self-assembly9
of nanoscale-objects from multiple components [29, 30]. Self-assembly is achieved by a simple10
dissolution of the fiber or particle precursors, and the resulting aggregates can easily be loaded with an11
active ingredient during the assembly process. For instance, Yu et al. prepared core/shell nanofibers by12
electrospinning, and were able to use these to self-assemble drug-loaded nanoparticles with13
controllable sizes [31]. Jin and co-workers have also prepared thermosensitive ketoprofen-loaded14
liposomes via the dissolution of electrosprayed composite microparticles of15
poly(N-isopropylacrylamide) and phosphatidyl choline [19]. During dissolution, the polymer matrix16
(which is typically made of a hydrophilic fast dissolving polymer) is believed to help confine the17
assembling components in close proximity, facilitating their self-aggregation to minimize any18
interactions between the aqueous medium used for assembly and hydrophobic components in the19
composites. The liposomes fabricated in this way are generally found to have uniform diameters, and20
high drug entrapment efficiencies. The fact that they are produced on demand from stable solid21
dispersions means that the stability issues commonly arising with liposomal formulations can be22
effectively ameliorated.23
24
The studies reported to date on stimuli-responsive liposomes have generally employed the evaporation25
method, and there is little work on using electrospinning or electrospraying to this end [19, 32]. In this26
study, we sought to exploit electrospraying to generate microparticles of Eudragit L 100 loaded with27
phosphatidyl choline (PC). When the microparticles were added to water, the PC was found to28
self-assemble into liposomes, and the physicochemical and biological properties of the liposomes were29





Eudragit L100 (average molecular weight ca. 135,000) was provided by Rohm GmbH (Darmstadt,5
Germany). Phosphatidyl choline (PC, extracted from soybean) was procured from the Sinopharm6
Chemical Reagent Co. (Shanghai, China). Chloroform and N,N-dimethylacetamide were purchased7
from the Traditional Industries Co. (Shanghai, China). Ketoprofen (KET) was obtained from Shanghai8
Greentech Industries Co. (Shanghai, China). Water was double distilled prior to use.9
10
2.2 Electrospraying11
Solutions were prepared by adding Eudragit L100 and PC to a mixture of12
chloroform/N,N-Dimethylacetamide (4:1 v/v) at room temperature and stirring for over 20 h. Details of13
the solution compositions are given in Table 1. The fully dissolved solutions were then loaded in 5 mL14
syringes, which were fitted with a stainless-steel flat-tipped needle (internal diameter 0.5 mm). The15
syringes were mounted on a syringe pump (KDS100, Cole-Parmer, Vernon Hills, IL, USA) and16
solution expelled at a rate of 1.0 mL/h. A voltage of 16 kV (ZGF- 2000 power supply, Shanghai Sute17
Electrical Co. Ltd., China) was supplied between the spinneret and a flat aluminium foil-covered18
collector (10×10 cm). The tip-to-collector distance was set at 25 cm, and experiments performed at 2519
± 2 ºC and relative humidity of 50 ± 5%. Six formulations were prepared in total (see Table 1).20
Table 1 The compositions of the solutions used for electrospraying21
Concentration F1 F2 F3 F4 F5 F6
CEudragit (%w/v) 2 2 2 2 2 2
CPC (%w/v) 0 0.5 1 1.5 2 1
CKET (%w/v) 0 0 0 0 0 0.4




52.3 Preparation of liposomes1
0.01 g of the electrosprayed particles were removed from the collector and added to 100 mL of2
phosphate buffered saline (PBS, pH=7.4) at room temperature.3
4
2.4 Characterization of microparticles5
The surface morphology of the microparticles was observed using a JSM-5600LV scanning electron6
microscope (SEM; JEOL, Tokyo, Japan). The average particle diameter was calculated through7
measuring more than 100 different particles in SEM images using the ImageJ software (National8
Institutes of Health, Bethesda, MA, USA).9
10
The physical form of the components in the microparticles and their interactions were analyzed by11
Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD). FTIR was performed12
using a Nicolet-Nexus 670 FTIR spectrometer (Nicolet Instrument Corporation, Madison, WI, USA).13
XRD was undertaken on a D/Max-BR diffractometer (Rigaku, Tokyo, Japan) with Cu-Kα radiation. 14
Thermogravimetric analysis (TGA; STA409PC instrument, Netzsch, Selb, Germany) was also15
performed to determine the thermal stability of the microparticles. 3-5 mg of dried sample was weighed16
into a crucible and analysis was carried out at a heating rate of 10 ºC/min under a flow of nitrogen.17
18
2.5 Characterization of liposomes19
The morphology of the liposomes was evaluated by transmission electron microscopy (TEM; H-80020
instrument, Hitachi, Tokyo, Japan). One drop of the liposome suspension (microparticles dissolved in21
phosphate buffered saline, pH=7.4) was dropped onto a carbon-coated copper grid and dried at 25 ºC.22
Particle size and zeta potential were measured with a Zetasizer Nano ZS instrument (Malvern23
Instruments, Malvern, UK). 0.02 g of the microparticles were added to 100 mL of PBS. As a control,24
pure PC was added to PBS at the same concentration (0.02 g in 100 mL) and the zeta potential and size25
recorded. In order to study the behavior of the liposomes under different pH conditions, the pH of the26
liposome suspensions was also adjusted to 4.5, 5.5, 6.0 and 6.527
28
2.6 Drug entrapment efficiency29
6The encapsulation efficiency (EE) of KET in the self-assembled liposomes from F6 was calculated as1
follows:2
EE = (Wt - Wf)/ Wt × 100%3
where Wt is the total drug mass in the electrosprayed particles and Wf the amount of free drug in the4
supernatant after liposome formation. The latter was isolated by ultracentrifugation (TGL-16G5
instrument, Anting Instrument Co. Ltd, Shanghai, China) for 30 min at 8,000 rpm, and the free drug6
content quantified by UV-vis spectrometry (UV-2101 spectrometer, Unico Instrument Co. Ltd,7
Shanghai, China) at 260 nm.8
9
2.7 In vitro drug dissolution tests10
For in vitro drug release experiments, 100 mg of the F6 microparticles were added to 10 mL of PBS11
buffer (pH 7.4) to form liposomes, and 3 mL of the liposome suspension then placed in a dialysis bag12
(MWCO=3500 Da). The filled dialysis bag was in turn immersed in a plastic bottle filled with 25 mL13
of PBS (pH = 7.4) or acetic acid buffer (pH = 4.5). The bottle was incubated at 37 ºC in a shaker bath14
operating at 100 rpm. Periodically, 1 mL aliquots were removed and replaced with the same volume of15
prewarmed buffer solution. Experiments were carried out in triplicate and the results are shown as16
mean ± S.D.17
18
3. Results and discussion19
3.1 Morphology of electrosprayed microparticles20
The ease by which polymer solutions can be processed by electrohydrodynamic approaches is21
dependent on their concentrations and molecular weights, which ultimately determine the viscosity and22
conductivity [33]. The molecular weight of PC is low (< 1000 Da), and thus it cannot be independently23
processed by electrospraying. SEM images of the product obtained from an attempt to process a 4 %24
w/v solution of PC in a mixture of chloroform and N,N-Dimethylacetamide (4:1 v/v) are shown in the25
Supplementary Information, Fig S1. A few irregularly shaped droplets can be seen, but there are no26
microparticles present. The addition of Eudragit L100 to the solution increases the solution viscosity27
and ensures that sufficient chain entanglements can occur to generate microparticles with well-defined28
morphologies. The presence of PC can however improve the morphology of the microparticles (over a29
pure Eudragit solution), since it acts as a surfactant [34].30
71
SEM images and size distribution of the electrosprayed microparticles (F1-F6) are given in Fig 1, with2
the details of their composition listed in Table 1. Most of the particles are spherical, with the exception3
of F1 where some irregularities are observed. In all cases there are a few fibers present as well as the4
particles. PC is an amphoteric ionic surface active agent. The addition of PC can lower the viscosity5
and surface tension of the electrospraying solution, which is conducive to the formation of spherical6
microparticles. The surfactant properties of PC are thought to contribute to the greater regularity of F27
as compared to F1 [35], as a result of its effect on the surface tension of the spinning solution. The8
average diameter of all the PC containing particles is around 1.6 µm, with F1 being a little smaller at9
1.2 µm. A comparison of F3 and F6, which are identical except for the presence of drug in the latter,10
reveals that the two materials are virtually indistinguishable, and thus the presence or absence of KET11
has little influence on the particle size. All the microparticles have approximately the same spherical12
shape, indicating that no significant phase separation occurred in the process.13
14
81
Figure 1 SEM images and diameter distributions of the electrosprayed particles. (a) F1, (b) F2, (c) F3,2
(d) F4, (e) F5, and (f) F6.3
4
3.2 Physical form of the components in the microparticles5
FTIR spectra are presented in Fig 2 (a). The particles of pure Eudragit (F1) show peaks at 1260 cm-16
and 1178 cm-1, which corresponded to the ester (C-O-C) stretching bands. A strong absorption at 17287
cm-1 is caused by the stretching of the carbonyl groups. In the spectrum of PC, vibrations at 2924 and8
2853 cm−1 correspond to symmetric and antisymmetric CH2 stretching from the hydrophobic tail9
regions. Peaks at 1250 and 1047 cm−1 are the result of phosphate group stretching vibrations, and the10
band at ca. 1739 cm−1 arises from the carbonyl group in PC.11
12
91
Figure 2 FTIR spectra (a) and X-ray diffraction patterns (b) of the electrosprayed particles.2
3
The spectra of the Eudragit/PC electrosprayed particles (F2–F5) contain all the characteristic peaks of4
both PC and Eudragit. However, some small shifts in frequency (for instance of the C=O group at5
around 1730 cm-1) arise, suggesting interactions between two components. There are much larger6
differences between the spectra of KET and the KET/Eudragit/PC particles (M6). Absorption bands of7
KET at 1655 and 1695 cm−1 can be attributed to the C=O group, with the latter corresponding to the8
dimer present in the crystalline form of the drug. After processing into microparticles, peaks at 17319
cm−1 and 1659 cm-1 are visible. The small shifts in the positions of the Eudragit and KET vibrations10
suggest the presence of intermolecular interactions between them. In addition, the absence of the 169511
cm-1 band indicates that the KET dimer is not present in the particles, suggesting that KET-KET12
interactions are replaced by interactions with the Eudragit or PC.13
14
The physical form of the components in the particles was also investigated by X-ray diffraction. The15
results are shown in Fig 2 (b). KET has a large number of distinct Bragg reflections visible in its16
pattern, demonstrating that it is a crystalline material. However, the Eudragit and PC materials are17
clearly amorphous, with only broad humps present. The patterns of all the PC loaded microparticles18
(F2–F5) also show merely the characteristic humps of amorphous systems. In the KET-loaded19
particles (F6), no Bragg reflections corresponding to the crystalline drug can be seen, which indicates20
that the electrospraying process has converted KET into the amorphous form. This finding is in21
complete agreement with numerous other studies in the literature [36, 37].22
23
Fig 3 illustrates the thermogravimetric (TG) and derivative thermogravimetric (DTG) curves for PC,24
10
F1, F3 and F6 (data for the remaining systems are shown in Fig. S2). There are three main stages in the1
profiles for all the samples: below 200 ºC, between 200-400 ºC and above 400 ºC. The first is due to2
the loss of physisorbed water. The second, most significant, loss can be attributed to the combustion of3
the organic species present in the sample. When the temperature is between 400-900 ºC, the mass of the4
samples remains essentially constant. The temperature of maximum decomposition rate of PC is at 3315
ºC, while those of Eudragit (F1) and PC-containing (F3) particles are at 376 and at 396 ºC, respectively.6
The addition of PC clearly has some effect on the thermal stability of the particles, although this is7
unlikely to be significant in the pharmaceutical setting given the elevated temperatures needed to drive8
decomposition. All the PC-containing particles exhibit the same behavior (see Fig 3 and Fig S2), and it9
can be seen that neither the amount of PC incorporated nor the presence of KET has any appreciable10
effect on the thermal stability.11
12
13
Figure 3 Thermal analysis of selected microparticles: (a) TG and (b) DTG.14
15
3.3 Liposome formation16
The formation of self-assembled liposomes from electrosprayed microparticles has been reported17
previously[19]. In agreement with previous research, when 0.1 g of the electrosprayed microparticles18
was added into 100 mL of PBS at pH 7.4, we observed the self-assembly of liposomes. The19
morphology and size of the liposomes were assessed by TEM and dynamic light scattering (DLS). The20
results are given in Fig 4 and Fig 5(a). In the TEM images (Fig 4), roughly spherical objects with21
core-shell structures can be seen. This indicates that there is some Eudragit polymer attached to the22




Figure 4 (a) a TEM image of liposomes assembled from F3 with (b) an enlarged image of single3
liposome.4
5
The results obtained from DLS agree well with the TEM data. The data depicted in Fig. 5(a) for PC, F36
and F6 show that the liposomes self-assembled from the Eudragit-based particles are rather larger than7
those made of PC alone. This is consistent with the suggestion from TEM that the liposomes from F38
and F6 are decorated with Eudragit at their surfaces. The average diameter of the F3 liposomes from9
DLS was ca. 224 nm, which is slightly larger than suggested from TEM. We believe that is caused by10
the increased degree of hydration in DLS. A comparison of the liposomes assembled from S3 and S611




Figure 5 DLS measurements recorded on the self-assembled liposomes: (a) size measurements from2
pure PC, F3 and F6 in PBS (pH=7.4), (b) size measurements on liposomes from F3 when the buffer pH3
was adjusted to different values, and (c) the mean diameters of liposomes obtained from F3 at different4
pH.5
6
The effect of a change in buffer pH on the liposome diameters was also measured, and the results are7
given in Fig 5(b) and (c). The mean diameters of the liposomes rise as the pH is decreased from 7.4 to8
4.5 (Fig 5(c)). This might tentatively be ascribed to changes in the ionization of the COOH groups of9
Eudragit and their interactions with water molecules [38, 39]. A lower pH value will result in less10
ionization, and thus reduced solubility of Eudragit L 100 and larger mean diameters of the liposomes as11
the Eudragit chains aggregate at the liposome surfaces. Zeta potential values were recorded at pH 7.412
(Table S1). It should be noted that the Eudragit-only particles and PC both gave negative values, and13
the liposomes from F3 – F6 possessed even more negative zeta potentials (at around -30 mV),14
indicating that the liposome suspensions should have good colloidal stability. Zeta potential values15
were also recorded at pH 4.5 (Table S2), and it was found that although the zeta potentials have16
increased they are still around – 20 mV at this lower pH. Thus, the liposomal suspension will be stable17
13
at both pH 4.5 and 7.4.1
2
3.4 In vitro drug release3
The entrapment efficiency of KET into the liposomes assembled from F6 in deionized water was4
determined to be approximately 75.0 ± 5.26%, which is higher than that of liposomes prepared using5
other methods[40]. This is in agreement with other reports that using electrospinning or spraying to6
prepare sacrificial templates for liposomal self-assembly can lead to improved drug entrapment7
efficiency [41, 42].8
9
Drug release profiles obtained at pH 7.4 and at pH 4.5 are shown in Fig 6. In the drug release10
experiment, F6 particles were dissolved in PBS, forming liposomes containing KET. They were then11
added to two different pH buffer solutions at 37 °C. At pH=7.4, KET release reached a plateau of12
around 80 % after 12 h, while when pH=4.5, the drug release was just 58 % after 12 h. The KET-loaded13
liposomes appeared to release more rapidly, and also release a greater final cumulative release14
percentage, at the higher pH value. However, ketoprofen is an acidic drug, so it will be more soluble at15
pH 7.4 than at pH 4.5. In order to be sure that the difference is due to the liposomes rather than the16
inherent solubility of the drug, we prepared control particles made of polyvinylpyrrolidone (PVP), PC,17
and KET (see Supplementary Information, Fig S3). The drug release profiles of liposomes18
self-assembled from the PVP/PC/KET microparticles are given in Fig S4. It is clear that the release19
profile is very similar at both pH 4.5 and 7.4, with only a small increase in the release rate and final20
cumulative percent release reached at pH 7.4 (compared to pH 4.5). The difference between the profiles21
is much more pronounced in the case of F6, and hence it can be concluded that it is the presence of22




Figure. 6 The in vitro drug release profiles of liposomes obtained from F6, measured at pH=4.5 and2
pH=7.4.3
4
The pH-responsive liposomes prepared in this work have a number of potential applications as targeted5
delivery systems. For example, in the human gastrointestinal tract, the pH value increases going from6
the stomach to the small intestine[43], which can be exploited to target release.7
8
3.5 Proposed mechanism of liposome self-assembly and drug release9
Based on the above results, it is clear that liposomes are easily formed from the Eudragit systems10
through self-assembly, and have pH-sensitive properties. A schematic diagram illustrating the proposed11
mechanism underlying this is shown in Fig 7. It is believed, on the basis of XRD and FTIR results, that12
the Eudragit and PC are mixed on the molecular level after electrospraying. This arises because the13
solvent evaporates very quickly, preventing the formation of a crystalline lattice, and instead hydrogen14
bonds form between the different components of the electrosprayed particles [35]. After the15
microparticles were dissolved in PBS, the Eudragit matrix dissolves quickly due to the ionization of its16
COOH groups to COO-, while the insoluble PC and KET self-assemble into liposomes[30]. However,17
there will be electrostatic attractions between the negatively charged carboxyl groups in Eudragit and18
the positively charged quaternary ammonium group in PC. Thus, it is likely that the Eudragit chains19
can become anchored on the liposomes formed through electrostatic attractions. When the pH value of20
the liposomal solution is below 6.0, the Eudragit chains will become insoluble due to the protonation of21
15
COO- groups, and thus they will aggregate at the liposome exteriors, packing tightly to minimize1
Eudragit/water interactions. This is in accordance with the increase in size as seen at pH < 6, and will2
help to prevent drug release from the liposomes.3
4
Figure. 7 A schematic diagram illustrating the self-assembly of liposomes from Eudragit/PC5
microparticles, and the effect of pH on the drug release.6
7
When the pH of the liposomal suspension is higher than 6, the Eudragit chains will ionize and dissolve,8
either becoming freed into solution or attached loosely around the liposomes. Given the reduction in9
size seen at higher pH, we suspect that the former is the dominant process, although the TEM data at10
pH 7.4 indicate that some Eudragit molecules remain associated with the liposomes. These effects11
leave the KET inside the liposomes with a clear path to diffuse out into solution, promoting its release.12
13
4. Conclusions14
In this study, we report a simple method to fabricate pH-sensitive liposomes. Eudragit/phosphatidyl15
choline (PC) composite microparticles were first prepared by electrospraying. Analogous particles were16
16
also prepared loaded with the model drug ketoprofen (KET). IR spectroscopy and X-ray diffraction1
data suggested that the components were mixed on the molecular level, while electron microscopy2
revealed the formation of spherical particles at around 1.2 – 1.6 µm in size. Liposomes could be3
self-assembled from the electrosprayed microparticles by dispersing them in a pH 7.4 phosphate buffer.4
Transmission electron micrographs suggested that these liposomes were roughly spherical in shape,5
with core/shell structures. The latter observation indicated the presence of Eudragit on the exterior of6
the PC core. In support of this idea, the resultant liposomes undergo distinct size changes when7
exposed to different pH environments. In vitro drug release experiments found that the liposomes had8
high entrapment efficiency for KET (ca. 75%) and can control the release of the incorporated KET in9
response to pH. Our findings indicate that the self-assembled pH-sensitive liposomes prepared in this10
work could have potential applications as advanced drug delivery systems.11
12
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